Phenelzine vs TRANYLCYPROMINE

Compare Phenelzine (Nardil) and TRANYLCYPROMINE (Tranylcypromine) — clinical data, side effects, and patient experiences.

Phenelzine

Nardil · MAOI

How it works

Irreversible, non-selective monoamine oxidase inhibitor that increases brain levels of serotonin, norepinephrine, and dopamine.

Approved for

Major Depressive Disorder

Social Anxiety Disorder

OralTablet

TRANYLCYPROMINE

Tranylcypromine, Parnate · MAOI

How it works

12.1 Mechanism of Action The mechanism of action of tranylcypromine tablets as an antidepressant is not fully understood, but is presumed to be linked to potentiation of monoamine ...

Approved for

and the need for dietary restrictions [see Contraindications (4)

Warnings and Precautions (5)

and the need for dietary restrictions ( 1

7 )

OralTablet

Quick Comparison

PhenelzineTRANYLCYPROMINE

Drug Class

MAOI

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Phenelzine

Drug Not Working

>10%

Depression

>10%

Headache

1-10%

Anxiety

1-10%

Weight Gain

1-10%

Nausea

0.1-1%

Insomnia

1-10%

Dizziness

1-10%

TRANYLCYPROMINE

Drug Not Working

>10%

Depression

1-10%

Headache

1-10%

Insomnia

1-10%

Nausea

1-10%

High Blood Pressure

1-10%

Fatigue

1-10%

Anxiety

0.1-1%

FDA Warnings

Phenelzine

No specific warnings

TRANYLCYPROMINE

5 WARNINGS AND PRECAUTIONS • Activation of Mania/Hypomania : May be precipitated by antidepressant treatment in patients with bipolar disorder
There was considerable variation in risk of suicidal thoughts and behaviors among drugs, but there was an increased risk identified in young patients for most drugs studied
There were differences in absolute risk of suicidal thoughts and behaviors across the different indications, with the highest incidence in patients with MDD
However, there is substantial evidence from placebo-controlled maintenance trials in adults with MDD that antidepressants delay the recurrence of depression and that depression itself is a risk factor for suicidal thoughts and behaviors

Clinical Trial Data

No head-to-head clinical studies found for Phenelzine vs TRANYLCYPROMINE.

Phenelzine vs TRANYLCYPROMINE: What You Should Know

Key Differences

Both Phenelzine and TRANYLCYPROMINE belong to the MAOI class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

TRANYLCYPROMINE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Loading comparison data...

Phenelzine vs TRANYLCYPROMINE

Compare Phenelzine (Nardil) and TRANYLCYPROMINE (Tranylcypromine) — clinical data, side effects, and patient experiences.

Phenelzine

Nardil · MAOI

How it works

Irreversible, non-selective monoamine oxidase inhibitor that increases brain levels of serotonin, norepinephrine, and dopamine.

Approved for

Major Depressive Disorder

Social Anxiety Disorder

OralTablet

TRANYLCYPROMINE

Tranylcypromine, Parnate · MAOI

How it works

12.1 Mechanism of Action The mechanism of action of tranylcypromine tablets as an antidepressant is not fully understood, but is presumed to be linked to potentiation of monoamine ...

Approved for

and the need for dietary restrictions [see Contraindications (4)

Warnings and Precautions (5)

and the need for dietary restrictions ( 1

7 )

OralTablet

Quick Comparison

PhenelzineTRANYLCYPROMINE

Drug Class

MAOI

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Phenelzine

Drug Not Working

>10%

Depression

>10%

Headache

1-10%

Anxiety

1-10%

Weight Gain

1-10%

Nausea

0.1-1%

Insomnia

1-10%

Dizziness

1-10%

TRANYLCYPROMINE

Drug Not Working

>10%

Depression

1-10%

Headache

1-10%

Insomnia

1-10%

Nausea

1-10%

High Blood Pressure

1-10%

Fatigue

1-10%

Anxiety

0.1-1%

FDA Warnings

Phenelzine

No specific warnings

TRANYLCYPROMINE

5 WARNINGS AND PRECAUTIONS • Activation of Mania/Hypomania : May be precipitated by antidepressant treatment in patients with bipolar disorder
There was considerable variation in risk of suicidal thoughts and behaviors among drugs, but there was an increased risk identified in young patients for most drugs studied
There were differences in absolute risk of suicidal thoughts and behaviors across the different indications, with the highest incidence in patients with MDD
However, there is substantial evidence from placebo-controlled maintenance trials in adults with MDD that antidepressants delay the recurrence of depression and that depression itself is a risk factor for suicidal thoughts and behaviors

Clinical Trial Data

No head-to-head clinical studies found for Phenelzine vs TRANYLCYPROMINE.

Phenelzine vs TRANYLCYPROMINE: What You Should Know

Key Differences

Safety Considerations

TRANYLCYPROMINE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.